Evidence map›Paper›PMID 39747012›Full record

ArticleNature communications2025

A Y chromosome-linked genome editor for efficient population suppression in the malaria vector Anopheles gambiae.

Ignacio Tolosana, Katie Willis, Matthew Gribble, Lee Phillimore, Austin Burt, Tony Nolan, Andrea Crisanti, Federica Bernardini

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Y-linked editors for invasive rodent control.Molecular biology and evolution · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Mosquito sex determination: recent advances and applications.Current opinion in insect science · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Engineering drive-selection balance for localized population suppression with neutral dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ignacio TolosanaDepartment of Life Sciences, Imperial College London, London, UK.ORCID 0000-0002-3766-8296
Katie WillisDepartment of Life Sciences, Imperial College London, London, UK.ORCID 0000-0001-5016-2380
Matthew GribbleDepartment of Life Sciences, Imperial College London, London, UK.
Lee PhillimoreDepartment of Life Sciences, Imperial College London, London, UK.
Austin BurtDepartment of Life Sciences, Imperial College London, London, UK.ORCID 0000-0001-5146-9640
Tony NolanDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK. tony.nolan@lstmed.ac.uk.ORCID 0000-0002-2982-8333
Andrea CrisantiDepartment of Life Sciences, Imperial College London, London, UK.ORCID 0000-0002-2406-4426
Federica BernardiniDepartment of Life Sciences, Imperial College London, London, UK. f.bernardini11@imperial.ac.uk.ORCID 0000-0001-7526-0155

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV006610 "Target Malaria Phase II"Gates Foundation INV-006610
6 · The paper itself

Abstract

Genetic control - the deliberate introduction of genetic traits to control a pest or vector population - offers a powerful tool to augment conventional mosquito control tools that have been successful in reducing malaria burden but that are compromised by a range of operational challenges. Self-sustaining genetic control strategies have shown great potential in laboratory settings, but hesitancy due to their invasive and persistent nature may delay their implementation. Here, instead, we describe a self-limiting strategy, designed to have geographically and temporally restricted effect, based on a Y chromosome-linked genome editor (YLE). The YLE comprises a CRISPR-Cas9 construct that is always inherited by males yet generates an autosomal dominant mutation that is transmitted to over 90% of the offspring and results in female-specific sterility. To our knowledge, our system represents a pioneering approach in the engineering of the Y chromosome to generate a genetic control strain for mosquitoes. Mathematical modelling shows that this YLE technology is up to seven times more efficient for population suppression than optimal versions of other self-limiting strategies, such as the widely used Sterile Insect Technique or the Release of Insects carrying a Dominant Lethal gene.

Indexed as

AnophelesCRISPR-Cas SystemsGene EditingMalariaMosquito ControlMosquito VectorsY ChromosomeAnimalsFemaleGenome, InsectMale

Identifiers

PMID39747012
PMCPMC11696527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.